Regulation of Private Health Insurance Markets: Lessons from Enrollment, Plan Type Choice, and Adverse Selection in Medicare Part D

Working Paper: NBER ID: w15392

Authors: Florian Heiss; Daniel McFadden; Joachim Winter

Abstract: We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets that control adverse selection and assure adequate access and coverage. We model Part D enrollment and plan choice assuming a discrete dynamic decision process that maximizes life-cycle expected utility, and perform counterfactual policy simulations of the effect of market design on participation and plan viability. Our model correctly predicts high Part D enrollment rates among the currently healthy, but also strong adverse selection in choice of level of coverage. We analyze alternative designs that preserve plan variety.

Keywords: No keywords provided

JEL Codes: C25; D12; H51; I11; I18


Causal Claims Network Graph

Edges that are evidenced by causal inference methods are in orange, and the rest are in light blue.


Causal Claims

CauseEffect
design of the Medicare Part D program (H51)enrollment rates (I24)
late enrollment penalty (H55)enrollment rates (I24)
government subsidies (H20)enrollment rates (I24)
late enrollment penalty (H55)adverse selection (D82)
adverse selection (D82)variety of plans available (G52)
adverse selection (D82)availability of comprehensive coverage plans (G52)
premiums rise (G52)average drug bill of those enrolling in comprehensive plans (I13)
absence of proper subsidies and risk adjustments (D52)viability of enhanced plans (O22)

Back to index